Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients-Reference-Cited by-同舟云学术

Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients

Published:2017-03 Issue:3 Volume:32 Page:645-650
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Morio Kei¹,Imamura Michio¹,Kawakami Yoshiiku¹,Morio Reona¹,Kobayashi Tomoki¹,Yokoyama Satoe¹,Nagaoki Yuko¹,Kawaoka Tomokazu¹,Tsuge Masataka¹,Hiramatsu Akira¹,Makokha Grace Naswa¹,Hayes C Nelson¹,Aikata Hiroshi¹,Miki Daiki²,Ochi Hidenori²,Honda Yoji³,Mori Nami³,Takaki Shintaro³,Tsuji Keiji³,Chayama Kazuaki¹²

Affiliation:

1. Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science; Hiroshima University; Hiroshima Japan

2. Laboratory for Digestive Diseases, SNP Research Center; The Institute of Physical and Chemical Research (RIKEN); Hiroshima Japan

3. Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13511/fullpdf

Reference22 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990